Crossref
Looking Beyond Drug Acquisition Costs: Generic Sugammadex and Quantitative Neuromuscular Monitoring
American Journal of Health-System Pharmacy · 07.11.2026
DOI: 10.1093/ajhp/zxag392 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Health-System Pharmacy, online erschienen am 07.11.2026. Verfasst von Dustin D Linn und 1 weiteren Autor:innen. Beteiligte Einrichtung: Philips North America, Cambridge, MA.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Philips North America, Cambridge, MA.
- Department of Pharmacy, Parkview Health, Fort Wayne, IN USA.
- Department of Anesthesiology and Perioperative Medicine, Mayo Clinic College of Medicine and Science, Jacksonville, FL USA.
ORCID-Profile: Dustin D Linn
Zitieren
APA
Linn, D. D., & Renew, J. R. (2026). Looking Beyond Drug Acquisition Costs: Generic Sugammadex and Quantitative Neuromuscular Monitoring. American Journal of Health-System Pharmacy. https://doi.org/10.1093/ajhp/zxag392
Vancouver
Linn DD, Renew JR. Looking Beyond Drug Acquisition Costs: Generic Sugammadex and Quantitative Neuromuscular Monitoring. American Journal of Health-System Pharmacy. 2026. doi:10.1093/ajhp/zxag392
BibTeX
@article{Linn2026,
author = {Linn, Dustin D and Renew, J Ross},
title = {Looking Beyond Drug Acquisition Costs: Generic Sugammadex and Quantitative Neuromuscular Monitoring},
journal = {American Journal of Health-System Pharmacy},
year = {2026},
doi = {10.1093/ajhp/zxag392}
}
EUVIMED